Medasys, a nuclear medicine computer manufacturer, and EncoreMedical Systems, a gamma camera refurbisher and reseller, haveagreed to merge. While details of the merger remain to be workedout and shareholder approval is required for both companies,
Medasys, a nuclear medicine computer manufacturer, and EncoreMedical Systems, a gamma camera refurbisher and reseller, haveagreed to merge. While details of the merger remain to be workedout and shareholder approval is required for both companies, executiveseagerly envision that the merger will create opportunities forboth sides.
The two businesses are complementary in nature, said WilliamE. Bach, president of the Palatine, IL-based Encore. He is confidentthat the logic behind the letter of intent to merge will leadto quick finalization of the deal, perhaps within a month.
"Our focus is on the front end, working on stands anddetectors; their focus is on computers, computer control and softwareprocessing--so it is a good match," Bach said.
Encore, which buys, rebuilds and resells primarily Siemensand GE equipment, will have direct access to computer systemsneeded to refurbish the gamma cameras. Ann Arbor, MI-based Medasyswill have a new way of marketing its computer systems and software.
The two companies also plan to leverage Encore's expertisein gamma camera detectors, electronics and mechanics and Medasys'products for the acquisition, processing and storage of nuclearimages to develop a new--not refurbished--integrated gamma cameraand computer system.
The merged companies would have the advantage of being ableto incorporate an extensive library of tested nuclear medicinesoftware owned by Medasys into the new system.
"The project (to develop the new system) is already underway, and we would expect to be able to make our first shipmentsby next winter or early spring," Bach reported at the Societyof Nuclear Medicine meeting last week in Toronto.
The system is being designed to do single-photon emission computedtomography (SPECT) studies, he said. No other product detailsare available.
The merged firm composed of Medasys and Encore is projectedto realize more than $12 million in sales during fiscal 1993,according to estimates released by the two companies. The saleof an integrated nuclear medicine scanner could boost revenuesin 1994.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.